LEXEO THERAPEUTICS INC
LXEO·52886X107·US·Common Stock·Healthcare - Biotechnology-13D/G
LXEO (LEXEO THERAPEUTICS INC) is held by 85 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($29.3M), RA CAPITAL MANAGEMENT, L.P. ($28.7M), Janus Henderson Group Ltd. ($28.5M). Net institutional sentiment: Mixed.
85
Holders
Avg rating(19 Elite)
$270M
Total Value
59% (93)
Fund Consensus
50 buying - 35 selling
Who's Trading
InsiderTNTownsend Richard NolanSell $116KJul 1, 2026
InsiderOMOtero Jose ManuelSell $21KJul 1, 2026
InsiderTETamayo Louis EdwardSell $21KJul 1, 2026
InsiderBPBhalla Narinder PalSell $99KJul 1, 2026
ActivistPBParadigm BioCapital Advisors LP8.3%May 15, 2026
ActivistSUSUVRETTA CAPITAL MANAGEMENT, LLC7.7%Apr 13, 2026
InsiderTNTownsend Richard NolanSell $313KApr 6, 2026
InsiderTNTownsend Richard NolanSell $65KFeb 18, 2026
13F: Insider & Congress:
Showing 1-20 of 93
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer